Plains GP (PAGP) Scheduled to Post Earnings on Friday

Plains GP (NYSE:PAGP) will post its quarterly earnings results before the market opens on Friday, May 3rd. Analysts expect Plains GP to post earnings of $0.53 per share for the quarter. Investors that wish to listen to the company’s conference call can do so using this link.

Plains GP (NYSE:PAGP) last announced its quarterly earnings results on Friday, February 9th. The pipeline company reported $0.27 earnings per share for the quarter, missing analysts’ consensus estimates of $0.33 by ($0.06). The business had revenue of $12.70 billion for the quarter, compared to analyst estimates of $12.88 billion. Plains GP had a net margin of 0.41% and a return on equity of 1.33%. On average, analysts expect Plains GP to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Plains GP Trading Down 0.5 %

Shares of PAGP stock opened at $18.92 on Friday. The stock has a market cap of $3.73 billion, a price-to-earnings ratio of 18.55 and a beta of 1.55. The company has a quick ratio of 0.87, a current ratio of 0.98 and a debt-to-equity ratio of 0.49. Plains GP has a fifty-two week low of $12.59 and a fifty-two week high of $19.77. The firm’s 50 day moving average price is $17.97 and its two-hundred day moving average price is $16.70.

Plains GP Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Wednesday, May 1st will be given a dividend of $0.3175 per share. The ex-dividend date is Tuesday, April 30th. This represents a $1.27 dividend on an annualized basis and a yield of 6.71%. Plains GP’s dividend payout ratio (DPR) is 124.51%.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on PAGP shares. StockNews.com raised shares of Plains GP from a “hold” rating to a “buy” rating in a research report on Monday, March 4th. The Goldman Sachs Group lifted their price target on shares of Plains GP from $14.50 to $16.00 and gave the company a “sell” rating in a research report on Friday, April 12th. UBS Group boosted their target price on shares of Plains GP from $22.00 to $23.00 and gave the stock a “buy” rating in a research report on Friday, April 12th. Stifel Nicolaus boosted their target price on shares of Plains GP from $18.00 to $22.00 and gave the stock a “buy” rating in a research report on Tuesday, April 16th. Finally, Scotiabank assumed coverage on shares of Plains GP in a research report on Monday, April 8th. They set a “sector outperform” rating and a $23.00 target price on the stock. Two research analysts have rated the stock with a sell rating, one has issued a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, Plains GP currently has an average rating of “Moderate Buy” and an average price target of $19.55.

Plains GP Company Profile

Plains GP Holdings, L.P., through its subsidiary, Plains All American Pipeline, L.P., owns and operates midstream infrastructure systems in the United States and Canada. It operates in two segments, Crude Oil and Natural Gas Liquids (NGLs). The company engages in the gathering and transporting crude oil and NGLs using pipelines, gathering systems, and trucks.